Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RUCAPARIB CAMSYLATE vs SABRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RUCAPARIB CAMSYLATE vs SABRIL: Safety Overview

Metric	RUCAPARIB CAMSYLATE	SABRIL
Total FAERS Reports	8,240	772
Deaths Reported	448	53
Death Rate	5.4%	6.9%
Hospitalizations	1,148	180
Average Patient Age	65.1 yrs	11.0 yrs
% Female Patients	95.2%	N/A
FDA Approval Date	Dec 19, 2016	N/A
Manufacturer	pharmaand GmbH	N/A
Route	ORAL	N/A
Marketing Status	Prescription	N/A